title: First-line treatment of acute lymphoblastic leukemia with pegasparaginase.
abstract: Acute lymphoblastic leukemia (ALL) accounts for almost 4000 cases annually in the United States, approximately two thirds of which are in children and adolescents. Treatment results of ALL have improved considerably in the past decade, due to an optimal stratification of patients and a rational use of different antileukemic agents among which L-asparaginase (L-ASNase) plays a fundamental role. This drug has been used in pediatric ALL chemotherapy protocols for almost 3 decades. In the 1970s and 1980s a chemically modified form of this enzyme called pegasparaginase (PEG-ASNase) was rationally synthesized to decrease immunogenicity of the enzyme and prolong its half-life. The different advantages of PEG-ASNase have been demonstrated in many clinical studies, the last of which underline the utility of this drug in front-line therapy of ALL. In this review, we discuss the pharmacological advantages and clinical potential of PEG-ASNase and its important use in first-line treatment of ALL.
authors.affiliation: Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", University of Bologna, Bologna, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Masetti
authors.forename: Andrea
authors.initials: A
authors.lastname: Pession
references.citation: Cancer Res. 1989 Aug 1;49(15):4363-8
references.pmid: 2743326
references.citation: Cancer Biochem Biophys. 1984 Jun;7(2):175-86
references.pmid: 6467175
references.citation: Pediatr Blood Cancer. 2006 Jan;46(1):18-25
references.pmid: 15929133
references.citation: Oncologist. 2007 Aug;12(8):991-8
references.pmid: 17766659
references.citation: Cancer. 1995 Mar 1;75(5):1176-81
references.pmid: 7850718
references.citation: Med Pediatr Oncol. 1979;7(4):335-40
references.pmid: 296786
references.citation: Am J Pediatr Hematol Oncol. 1979 Spring;1(1):9-13
references.pmid: 295576
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1474-8
references.pmid: 8434007
references.citation: Cancer Res. 1979 Oct;39(10):3893-6
references.pmid: 383278
references.citation: Cancer Res. 1977 Feb;37(2):535-40
references.pmid: 264412
references.citation: Blood. 2000 Jun 1;95(11):3310-22
references.pmid: 10828010
references.citation: Leukemia. 1989 Apr;3(4):294-7
references.pmid: 2564453
references.citation: Ann N Y Acad Sci. 1990;613:95-108
references.pmid: 2076022
references.citation: Leuk Lymphoma. 1993;10 Suppl:153-7
references.pmid: 8481665
references.citation: Br J Haematol. 2003 Dec;123(5):836-41
references.pmid: 14632774
references.citation: Leuk Lymphoma. 1993;10 Suppl:147-50
references.pmid: 8481663
references.citation: Crit Rev Oncol Hematol. 2007 Mar;61(3):208-21
references.pmid: 17011787
references.citation: Clin Cancer Res. 1999 Dec;5(12):4041-7
references.pmid: 10632337
references.citation: Eur J Pediatr. 1999 Dec;158 Suppl 3:S143-6
references.pmid: 10650855
references.citation: Blood. 2000 Sep 1;96(5):1709-15
references.pmid: 10961868
references.citation: Formulary. 1995 Jul;30(7):388-93
references.pmid: 10151730
references.citation: J Clin Oncol. 1993 Sep;11(9):1780-6
references.pmid: 8355045
references.citation: J Exp Med. 1953 Dec;98(6):565-82
references.pmid: 13109110
references.citation: Int J Cancer. 1992 Feb 20;50(4):644-8
references.pmid: 1537631
references.citation: Drugs. 2007;67(15):2153-71
references.pmid: 17927282
references.citation: Thromb Haemost. 2000 Jun;83(6):840-3
references.pmid: 10896235
references.citation: N Engl J Med. 1986 Sep 11;315(11):657-63
references.pmid: 2943992
references.citation: N Engl J Med. 2006 Mar 23;354(12):1323-4
references.pmid: 16554542
references.citation: Ann Intern Med. 1971 Jun;74(6):893-901
references.pmid: 5281051
references.citation: South Med J. 1987 Sep;80(9):1133-6
references.pmid: 3306944
references.citation: Blood. 2002 Apr 15;99(8):2734-9
references.pmid: 11929760
references.citation: Leukemia. 2008 Sep;22(9):1665-79
references.pmid: 18580955
references.citation: Cancer Treat Rep. 1979 Jun;63(6):1127-32
references.pmid: 466651
references.citation: Cancer Chemother Pharmacol. 2001;47(1):83-8
references.pmid: 11221967
references.citation: Jpn J Cancer Res. 1986 Dec;77(12):1264-70
references.pmid: 3102431
references.citation: Cancer Res. 1970 Sep;30(9):2297-305
references.pmid: 4920133
references.citation: J Pediatr Hematol Oncol. 2004 Apr;26(4):217-26
references.pmid: 15087948
references.citation: Blood. 2007 Apr 1;109(7):2744-50
references.pmid: 17132721
references.citation: J Lab Clin Med. 1970 May;75(5):763-70
references.pmid: 4909251
references.citation: Essays Biochem. 1989;24:1-40
references.pmid: 2676522
references.citation: Br J Haematol. 1990 Apr;74(4):465-70
references.pmid: 2189489
references.citation: Expert Opin Pharmacother. 2007 Aug;8(12):1977-84
references.pmid: 17696798
references.citation: Expert Opin Biol Ther. 2009 Jan;9(1):111-9
references.pmid: 19063697
references.citation: J Exp Med. 1953 Dec;98(6):583-606
references.pmid: 13109111
references.citation: Ann Pharmacother. 1997 May;31(5):616-24
references.pmid: 9161659
references.citation: J Pediatr. 1982 Jun;100(6):990-5
references.pmid: 6953222
references.citation: Klin Padiatr. 2005 Nov-Dec;217(6):321-6
references.pmid: 16307417
references.citation: N Engl J Med. 2006 Jan 12;354(2):166-78
references.pmid: 16407512
references.citation: Cancer Treat Rev. 2002 Apr;28 Suppl A:13-6
references.pmid: 12173407
references.citation: BioDrugs. 2008;22(5):315-29
references.pmid: 18778113
references.citation: Blood. 2002 Mar 15;99(6):1986-94
references.pmid: 11877270
references.citation: Drug Metab Dispos. 1986 May-Jun;14(3):349-52
references.pmid: 2872037
references.citation: Leukemia. 2000 Mar;14(3):356-63
references.pmid: 10720126
references.citation: J Pharmacol Exp Ther. 1981 Feb;216(2):410-4
references.pmid: 7007618
references.citation: Med Pediatr Oncol. 1977;3(1):101-15
references.pmid: 840159
references.citation: J Clin Oncol. 2005 Oct 1;23(28):7161-7
references.pmid: 16192600
references.citation: J Clin Oncol. 1987 May;5(5):811-7
references.pmid: 3572467
references.citation: Eur J Pediatr. 1999 Dec;158 Suppl 3:S147-50
references.pmid: 10650856
references.citation: Leukemia. 1997 Nov;11(11):1858-61
references.pmid: 9369418
references.citation: Cancer Chemother Pharmacol. 2001 Jul;48(1):77-82
references.pmid: 11488528
references.citation: Leukemia. 2003 Nov;17(11):2254-6
references.pmid: 14523472
references.citation: Am J Pediatr Hematol Oncol. 1986 Summer;8(2):99-104
references.pmid: 3526939
references.citation: Cancer Chemother Pharmacol. 2002 Feb;49(2):149-54
references.pmid: 11862429
references.citation: J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):175-81
references.pmid: 11990302
references.citation: Blood. 2003 Dec 15;102(13):4541-6
references.pmid: 12920041
references.citation: Annu Rev Pharmacol. 1970;10:421-40
references.pmid: 4911021
references.citation: Biochemistry. 1969 Jun;8(6):2386-93
references.pmid: 4895020
references.citation: Blood. 2001 Mar 1;97(5):1211-8
references.pmid: 11222362
references.citation: Biochem Pharmacol. 1969 Oct;18(10):2578-80
references.pmid: 4935103
references.citation: Leukemia. 2004 Jun;18(6):1072-7
references.pmid: 15057247
references.citation: Med Pediatr Oncol. 1977;3(4):387-400
references.pmid: 337095
references.citation: Clin Pharmacokinet. 2005;44(4):367-93
references.pmid: 15828851
references.citation: Cancer. 1976 Oct;38(4):1515-23
references.pmid: 991074
references.citation: Biochim Biophys Acta. 1967 May 30;138(3):637-9
references.pmid: 6036864
references.citation: Biochem Biophys Res Commun. 1968 Apr 5;31(1):43-7
references.pmid: 4869945
references.citation: Cancer Chemother Pharmacol. 1993;32(4):310-4
references.pmid: 8324873
references.citation: Cancer. 1999 Oct 1;86(7):1203-9
references.pmid: 10506705
references.citation: Arch Biochem Biophys. 1964 May;105:450-2
references.pmid: 14186753
references.citation: N Engl J Med. 1969 Nov 6;281(19):1028-34
references.pmid: 4898857
references.citation: Biochemistry. 1970 Sep 1;9(18):3585-90
references.pmid: 4928351
references.citation: Hoppe Seylers Z Physiol Chem. 1980;361(2):105-17
references.pmid: 6766894
references.citation: Invest New Drugs. 1990 Feb;8(1):125-30
references.pmid: 2345067
references.citation: Cancer. 2007 Jul 1;110(1):103-11
references.pmid: 17516438
references.citation: Blood. 2007 May 15;109(10):4164-7
references.pmid: 17264295
references.citation: Br J Haematol. 2001 Apr;113(1):115-9
references.pmid: 11328290
references.citation: Haematologica. 2006 Jan;91(1):24-31
references.pmid: 16434367
references.citation: Anticancer Res. 1981;1(6):373-6
references.pmid: 7046623
references.citation: J Clin Oncol. 2000 Apr;18(7):1525-32
references.pmid: 10735901
references.citation: Semin Hematol. 2009 Jan;46(1):64-75
references.pmid: 19100369
references.citation: Biochemistry. 1967 Mar;6(3):721-30
references.pmid: 5337885
references.citation: Am J Physiol. 1997 May;272(5 Pt 1):C1691-9
references.pmid: 9176161